***Response from Tracy Gibbs today ***THIS IS THE PART TO PAY ATTENTION TO!!! QUOTE: We do have some press releases coming up shortly and I like your idea of a separate website for our R&D division.
(I am working to develop a few supps for my supplement company with NNRX)
Thanks and for the insight. That's funny. We've been doing custom formulations for companies for over 20 years. We have about 64 accounts in 16 countries. Making products for other companies generates about 80% of our gross revenue. But you're right, we don't even have a webpage for that division of our company. Our website only lists our own product formulations and our own brand. We do have some press releases coming up shortly and I like your idea of a separate website for our R&D division. Will take that into consideration. Thanks for your support. I'll be waiting for your NDA. Regards Tracy
Also company retweeted this today - A GOOD SIGN! Nutranomics Inc. ?@NutranomicsInc 9h9 hours ago @SubPennyPlays NNRX's GenEpic works! http://genepic.com/clinical-trial/ 60 pats w/ prostate cancer, all but 4 showed no sign of cancer at end of trial.
***MORE GOOD NEWS: SS HAS NOT INCREASED! EMPIRE STOCK T/A RESPONSE FROM TODAY! RE: NNRX share count Today at 10:52 am
Good Morning Ben,
Our records indicate that the current issued and outstanding share count for NNRX is 390,385,520.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.